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Abstract
Background: Primary hyperparathyroidism is an endocrinopathic condition characterized by hypersecretion of
parathyroid hormone. Excess parathyroid hormone results in an altered state of osseous metabolism involving bone
resorption and tissue change known as osteitis fibrosa cystica, which is the end stage of primary hyperparathyroidism.
Osteitis fibrosa cystica is associated with the development of brown tumors, which are rare because
hyperparathyroidism is now usually diagnosed and treated before symptoms develop. Brown tumors are rarely the first
symptom of hyperparathyroidism and can occasionally be mistaken for malignancy.
Case Presentation: We herein report three cases of primary hyperparathyroidism with an unusual presentation of
brown tumors. All three patients were Asian. In the first case, a 42-year-old man was admitted with a mass mimicking a
malignant bone neoplasm in the right mandible as the first manifestation of primary hyperparathyroidism. The second
case involved a 25-year-old man admitted with a fracture of his right femur. The third case involved a 43-year-old man
with multiple brown tumors in both lower limbs. All three patients underwent successful parathyroidectomy for
parathyroid adenomas; one case was complicated by a papillary thyroid carcinoma.
Conclusion: Complete evaluation of the medical history and biochemical and radiographic findings is necessary to
achieve a correct diagnosis and avoid unnecessary bone resections in patients with primary hyperparathyroidism.
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Background
The parathyroid glands secrete parathyroid hormone
(PTH), which is involved in regulating the metabolism
of calcium and phosphorus. PTH plays an important
role in tooth development and bone mineralization and
increases bone resorption. Excessive secretion of PTH is
termed hyperparathyroidism (HPT), which is an endo-
crine condition categorized as primary, secondary, or
tertiary. Primary HPT (PHPT) is an endocrinopathic
condition characterized by hypersecretion of PTH,
which may be caused by an adenoma (solitary or mul-
tiple), idiopathic hyperplasia, or a parathyroid carcin-
oma. Secondary HPT is caused by hypocalcaemia or
vitamin D deficiency acting as a stimulus of excessive
PTH production. Chronic renal failure is the main cause
of secondary HPT. Tertiary HPT is caused by the devel-
opment of autonomous parathyroid hyperplasia after
long-standing secondary HPT, most often in patients
with renal failure [1]. Most cases of PHPT (80 %–85 %)
are caused by a solitary adenoma, 15 % to 20 % are due to
parathyroid gland hyperplasia, and <0.5 % are caused by
parathyroid carcinoma [2, 3]. Renal calculi have been re-
ported in 10 % to 25 % of cases, and the frequency of bone
disease among patients with PHPT is 10 % to 20 % [4].
Skeletal involvement in classic PHPT is characterized
by a strikingly high rate of osteoclastic bone resorption
and is accompanied by a cellular repair process that re-
sults in the accumulation of fibrous stroma and connect-
ive tissue cells along with multinucleated giant cells.
Thus, brown tumors have been described as resulting
from an imbalance between osteoclastic and osteoblastic
activity, resultant resorption with fibrous replacement of
the bone, and eventual osteitis fibrosa cystica (OFC).
Brown tumors are reactive lesions and do not repre-
sent true neoplasms. They may be difficult to diagnose
because they present clinically and radiologically as
other diseases such as giant cell tumors, multiple bone
metastases, or multiple myeloma [5, 6]. Moreover, from
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a histological perspective, differential diagnosis among
brown tumors, giant cell granulomas, and giant cell
bone tumors may be very difficult without an accurate
and complete preoperative clinical evaluation.
Brown tumors involving the jaw bones as the first mani-
festation of PHPT and pathological fractures that lead to a
diagnosis of PHPT are not commonly described [7–11].
We herein report three Asian patients with PHPT with an
unusual first manifestation of brown tumors.
Case presentations
Case 1
A 42-year-old man with no known disease history no-
ticed a mass on the right side of his face, which grad-
ually generalized. One month later, he presented to our
hospital for an examination. He had no other associated
complaints or any significant family history. Intraoral
examination revealed a reddish, nontender, hard, ill-
defined sessile swelling in the right side of the mandible.
Panoramic radiography revealed a well-defined, osteo-
lytic lesion measuring 40 × 30 mm in the right man-
dible (Fig. 1a, b). Computed tomography (CT) revealed
an expansionary cystic bone lesion that penetrated the
cortex, forming a peripheral soft tissue mass (Fig. 1c).
The bone mass was suspected to be a malignant neo-
plastic lesion. m99Tc bone scintigraphy revealed multiple
hypermetabolic foci in the right acromion, left maxilla,
and bilateral mandibular bone. Urinary tract ultrason-
ography revealed multiple nephroliths on the left side
and mild hydronephrosis caused by lower ureteral cal-
culi on the right side. Biopsy of the right mandibular
mass revealed spindle-shaped mesenchymal cells with a
large number of multinucleated giant cells throughout
the lesion. The benign lesion was identified as a giant
cell granuloma. The mandibular lesion was removed
before performing magnetic resonance imaging (MRI)
of the thyroid gland and neck.
Laboratory data are shown in Table 1 and included a
PTH level of 939.8 pg/ml (reference range, 15–88 pg/
ml), serum calcium level of 2.93 mmol/L (reference
range, 2.08–2.80 mmol/L), and alkaline phosphatase
(ALP) level of 422 U/L (reference range, 45–125 U/L)
before parathyroidectomy. Urine testing was positive for
calcium oxalate crystals. Glucose, bilirubin, uric acid,
protein, albumin, and globulin levels were all normal.
Serum immunoelectrophoresis findings were also nor-
mal. The concentrations of IgG, IgA, IgM, C3, C4, and
C-reactive protein were within the normal range.
These findings suggested that PHPT initially manifested
as a brown tumor of the jaw. Contrast MRI of the neck
confirmed the existence of a 2.5-cm nodular mass on the
lower right parathyroid (Fig. 1d). Mini-invasive parathy-
roidectomy was performed. Histopathology confirmed
that the resected lesion was a parathyroid adenoma.
The patient recovered well postoperatively, and his
serum calcium (2.13 mmol/L) and PTH (66.40 pg/ml)
levels normalized within 1 week. Detailed biochemical
data observed before and after parathyroidectomy are
shown in Table 1. The patient was lost to long-term
follow-up after clinical improvement.
Case 2
A 25-year-old man developed swelling and pain of the
right shoulder after tripping on a step and falling onto his
right side. Two weeks later, he was hospitalized with swell-
ing and deformity of the right thigh when crossing the
legs. Radiography confirmed a comminuted fracture of the
femur secondary to a lytic bone lesion (Fig. 2b). Chest
radiography showed extensive osteolysis of the thoracic
bones and several old fractures (Fig. 2a). His calcium level
was 3.59 mmol/L (reference range, 2.08–2.80 mmol/L)
and creatinine level was 94 μmol/L (reference range, 45–
133 μmol/L). Serum immunoelectrophoresis findings were
normal. The levels of IgG, IgA, IgM, alpha-fetoprotein,
and carcinoembryonic antigen 2 were normal. The circu-
lating level of PTH was 1399.80 pg/ml (reference range,
15–88 pg/ml), and the diagnosis of PHPT was confirmed.
CT of the neck revealed a nodular mass measuring 3.5 ×
2.5 × 2.0 cm in the lower right parathyroid gland (Fig. 2c).
Parathyroidectomy was performed, and the lesion was
histologically confirmed to be a benign parathyroid ad-
enoma. The patient recovered well postoperatively, and
his serum calcium (2.08 mmol/L) and PTH (65.40 pg/
ml) levels normalized within 2 weeks. The patient’s bio-
chemical data before and after parathyroidectomy are
shown in Table 1. Surgical intervention for the patho-
logic fracture was contraindicated because of serious
osteoporosis. Thus, conservative treatment involving
fracture reduction and splint fixation was performed.
This patient was still being followed up at the time of
this writing.
Case 3
A 43-year-old man presented with a 1-month history of left
foot swelling with no other associated complaints or sig-
nificant medical history. The swelling was mildly tender in
the left fifth metatarsal bone with no reddish color or
throbbing sensation. Radiography revealed multiple mild
but expansive lytic bone lesions in the bilateral distal tibia
and left fifth metatarsal bone (Fig. 3a–c). Biopsy of the left
fifth metatarsal bone and left distal tibia lesions revealed
numerous osteoclast-like giant plurinuclear cells without
necrosis, mitoses, or histological signs of malignancy; these
findings were compatible with a giant cell tumor of the
bone. The patient underwent excision of the left fifth meta-
tarsal bone and curettage of the lesion in the left distal
tibia. Three weeks after surgery, the first medical and la-
boratory follow-up examinations revealed a serum calcium
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level of 2.91 mmol/L (reference range, 2.08–2.80 mmol/L),
ALP level of 1154 U/L (reference range, 45–132 U/L), and
PTH level of 1084.45 pg/ml (reference range, 15–88 pg/
ml). A review of the patient’s medical records revealed hy-
percalcemia, which had been underestimated at the first
examination. The patient had no family history of parathy-
roid disease. The creatinine level was 51 μmol/L (reference
range, 45–133 μmol/L).
PHPT was suspected. Enhancement CT of the neck
revealed a round mass measuring 2.7 × 1.4 cm behind
and below the left thyroid lobe and a round lesion meas-
uring 1.5 × 1.0 cm located in the left thyroid lobe
(Fig. 3d). Parathyroidectomy was performed. Histological
examination confirmed the diagnosis of adenoma of the
left parathyroid gland and papillary thyroid carcinoma of
the left thyroid lobe. Biochemical data observed before
and after parathyroidectomy are shown in Table 1. After
a review of bone slices, the final diagnosis was a brown
tumor probably due to long-standing underestimated
PHPT.
Conclusions
The incidence of PHPT is difficult to assess and may
vary widely from 0.4 to 21.6 cases per 100,000 person-
years [12, 13]. Additionally, racial or regional differences
in the incidence and prevalence of PHPT may exist [14].
The incidence of PHPT is nearly two or three times
more common in women than in men [6, 14, 15]. In
most patients with PHPT (80 %–85 %), the disease de-
velops due to a parathyroid adenoma, in 15 % to 20 %
due to parathyroid gland hyperplasia, and in <0.5 % due
to parathyroid carcinoma [2, 3]. Before the 1970s, PHPT
was a disease caused by recurrent kidney stones, brown
tumors, neuromuscular dysfunction, and symptomatic
hypercalcemia [16, 17]; today, it can be diagnosed in the
early and asymptomatic period because of advances in
Fig. 1 (a, b) Panoramic radiograph revealing a well-defined osteolytic lesion in the right mandible. (c) Axial CT scan showing an expansionary
cystic bone lesion of the right mandible, penetrating the cortex and forming a peripheral soft tissue mass. (d) Enhanced MRI of the neck showing
a 2.5-cm enhancing nodular mass on the right parathyroid
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blood analysis and a growing awareness of this disease
[18–21]. However, normocalcemic HPT may be an early
form of the disease [8, 22].
Although many systems are affected in patients with
PHPT, the most pronounced alternations are observed
in the bone. Classic skeletal lesions are bone resorption,
OFC, and brown tumors. With the recent development
of imaging and laboratory screening methods, however,
hypercalcemia due to primary or secondary HPT can
often be detected early, with a decrease in frequency of
OFC and brown tumors. A brown tumor is the localized
form of OFC [23]. It is more common in people aged >50
than <50 years and three times more common in women
than in men; the preferential locations are the facial
skeleton (particularly the mandible) [20] and the ends of
long bones and ribs [24]. The incidence of brown tumors
in patients with PHPT is 1.5 % to 1.7 % [25], and these tu-
mors rarely present as the first manifestation of PHPT, as
in our cases.
The term “brown tumor” is derived from the charac-
teristic appearance of a brown-colored material within
the cystic lesion, which is caused by high vascularity,
hemorrhage, and hemosiderin deposits [26]. Brown tu-
mors are not true neoplasms, but they can be locally ag-
gressive and mimic malignancies. In some cases, they
may lead primarily to the differential diagnosis of other
giant cell lesions (reparative giant cell granuloma, cher-
ubism, aneurysmal bone cyst, or true giant cell tumor)
Table 1 Laboratory data before and after parathyroidectomy in the three patientsPTH, parathyroid hormone; ALP, alkaline
phosphatase; Ca, calcium; −, not available
Reference range, adults Admission Before parathyroidectomy After parathyroidectomy
PTH level (pg/ml) 15–88 Case 1: − Case 1: 939.80 Case 1: 66.40
Case 2: − Case 2: 1399.80 Case 2: 65.40
Case 3: − Case 3: 1084.45 Case 3: 80.20
Ca level (mmol/L) 2.08–2.80 Case 1: 3.18 Case 1: 2.93 Case 1: 2.13
Case 2: 3.59 Case 2: 3.37 Case 2: 2.56
Case 3: 2.91 Case 3: 3.53 Case 3: 2.24
Phosphorus level (mmol/L) 0.80–1.50 Case 1: − Case 1: − Case 1: 0.75
Case 2: 0.78 Case 2: − Case 2: 0.52
Case 3: − Case 3: − Case 3: −
ALP (U/L) 45–125 Case 1: 422 Case 1: − Case 1: −
Case 2: 1367 Case 2: − Case 2: −
Case 3: 1154 Case 3: 387 Case 3: −
Creatine (μmol/L) 45–133 Case 1: 131 Case 1: − Case 1: −
Case 2: 94 Case 2: 108 Case 2: 217
Case 3: 51 Case 3: 60 Case 3: 66
Fig. 2 (b) Radiographs of a pathological fracture of the right femur. (a) Chest radiograph showing extensive osteolysis of the thoracic bones and
several old fractures on the right scapula and ribs (arrow). (c) CT scan of the neck (axial view) showing a 3.5 × 2.5 × 2.0cm nodular mass on the
right parathyroid
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or a metastatic lesion because of the rarity of multiple
lesions of this type [5, 27, 28]. This was demonstrated in
our first patient, in whom medical imaging findings sug-
gested a malignant bone neoplasm.
On radiography and CT, brown tumors are seen as lytic
lesions or sclerotic lesions with regular borders and no
cortical disruption, periosteal reaction, or inflammatory
signs [29]. MRI shows variable intensities on T2-weighted
images and intense enhancement on T1-weighted contrast
images [9, 30]. The appearance on radiographs and CT is
variable and not always specific and can mimic a malig-
nant tumor [4, 5, 31]. In our first patient, the expansionary
cystic bone lesion in the right mandible penetrated the
cortex and formed a peripheral soft tissue mass, mimick-
ing a malignant neoplastic lesion and thus confusing clini-
cians regarding the correct diagnosis and therapeutic
management.
Some large bone defects increase the risk of spontan-
eous fracture, a rare complication of PHPT. The reported
crude fracture rate in patients with PHPT has been docu-
mented as 15 per 1000 person-years (compared with 8 per
1000 in controls) [32]. However, PHPT revealed by
pathological fracture, as in our third patient, is extremely
rare [24, 32].
Brown tumors exhibit no pathognomonic histological
changes and are characterized by numerous giant cells,
diffused or arranged in clusters, in a background of
mononuclear oval-to-spindle stromal cells [27]. These
giant cells are similar to those in other giant cell lesions
such as reparative giant cell granulomas, cherubism, and
aneurysmal bone cysts. Therefore, distinguishing a brown
tumor from other giant cell lesions on the basis of histo-
logical examination may be difficult [33, 34]. A definitive
diagnosis is only possible by comparing the clinical mani-
festations and radiological and laboratory test results that
differentiate the lesions.
The treatment of choice for PHPT is parathyroidec-
tomy, and the best treatment of brown tumors is cure of
the underlying PHPT [3, 17, 18]. However, the fracture
should undergo curettage, associated enucleation, and
stabilization in patients with large lesions or lesions that
persistently grow despite treatment, persist for more
than 6 months, disrupt the function of the affected
organ, or are associated with previous fracture fragility
[35–38]. Extensive bone resection was not performed for
our third patient because he had serious osteoporosis,
making surgical intervention a high-risk procedure. In
some cases, resection is performed only to achieve a de-
finitive diagnosis [5, 28, 38].
In summary, PHPT is now usually detected in the
early and asymptomatic phase because of recent im-
provements in analytical techniques. A brown tumor is a
benign clinical entity appearing as an extremely rare
manifestation of HPT and an uncommon cause of
pathological fractures, which can be difficult to distin-
guish from other tumors, tumor-like lesions, and meta-
static disease. When a patient, especially a middle-aged
patient, presents with unexplained lytic bone lesions or
pathological fractures, surgeons, endocrinologists, and
especially radiologists should be reminded of this un-
usual presentation of PHPT to avoid unnecessary surgi-
cal removal. Our cases highlight the importance of a
thorough diagnostic work-up for PHPT. A definitive
diagnosis is only possible upon completion of clinical,
radiological, and biochemical analysis.
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CT scan of the neck showing a mass lesion measuring 2.7 × 1.4 cm on the left parathyroid (arrow) and a round lesion measuring 1.5 × 1.0 cm in
the left thyroid lobe (dotted arrow)
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